WuXi NextCode Sequencing Facility Receives CAP Accreditation | GenomeWeb

NEW YORK (GenomeWeb) –WuXi AppTec subsidiary WuXi NextCode said today that its sequencing facility in Shanghai, China has been accredited by the College of American Pathologists.

The company also said that the Shanghai lab is the first such lab in China to be licensed by the State of California, allowing the company to process samples from the state. WuXi NextCode is also the only sequencing facility in China with CLIA certification from the US Centers for Medicare and Medicaid, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.

Feb
23
Sponsored by
NuGEN

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.